Kapitalo Investimentos Ltda Eli Lilly & CO Transaction History

Kapitalo Investimentos Ltda

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $92,975 - $124,387	-157 Reduced 30.02%	366 $285 Million
Q4 2023 Mar 29, 2024	BUY	$525.19 - $619.13 $274,674 - $323,804	523 New	523 $305 Million
Q3 2023 Mar 29, 2024	SELL	$434.7 - $599.3 $435,134 - $599,899	-1,001 Closed	0 $0
Q2 2023 Mar 29, 2024	BUY	$350.74 - $468.98 $351,090 - $469,448	1,001 New	1,001 $469 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $717B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

Stay updated on Kapitalo Investimentos Ltda with notifications on news.